Skip to main content
OpenTrials
Completed

NCT Number: NCT01841879

Mumbai Worksite Tobacco Control Study

The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies in 20 manufacturing worksites in the greater Mumbai region of India.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Use Cessation Behavior Health Behavior

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Healis-Sekhsaria Institute for Public Health

Navi Mumbai, Maharshtra, India

About this study

Through 6 health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use.

Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India
  • Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining "workers" as anyone who is on the company roster, regardless of whether they're permanent or contractual
  • Companies must be autonomous decision-makers and allow us to function at their worksite
  • Companies must be willing to provide us with a current employee roster

Exclusion criteria

  • Employees do not speak English, Hindi, or Marathi

Treatment and study plan

Intervention program

Behavioral

Receives an integrated tobacco control and occupational health (OH) intervention (The Healthy, Safe, and Tobacco-Free Worksites program) aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies.

Through six health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use.

Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.

Other names: Healthy, Safe, and Tobacco-Free Worksites Program

Delayed Intervention

Behavioral

Receives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.

Primary outcomes

  1. Tobacco use cessation

    Time frame: 6-month post intervention

Secondary outcomes

  1. Changes in company tobacco policy

    Time frame: 6-month post intervention

Sponsors and collaborators

Lead sponsor

Harvard School of Public Health (HSPH)

Other

Collaborators

  • Carelon Research
  • Dana-Farber Cancer Institute
  • Healis-Sekhsaria Institute for Public Health
  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2010
Primary completion
2016
Study completion
2016
First posted
Apr 29, 2013
Registry last updated
Apr 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.